We are live on ! Find out more
KA

Kovack Advisors Portfolio holdings

AUM $2.08B
1-Year Est. Return 38.95%
This Fund
S&P 500
This Quarter Est. Return
+0.13%
1 Year Est. Return
+38.95%
3 Year Est. Return
+118.27%
5 Year Est. Return
+142.08%
10 Year Est. Return
+472.03%
AUM
$920M
AUM Growth
+$41.6M
Cap. Flow
+$50.7M
Cap. Flow %
5.51%
Top 10 Hldgs %
21.24%
Holding
787
New
83
Increased
356
Reduced
204
Closed
80

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.29%
2 Technology 19.78%
3 Consumer Discretionary 8.37%
4 Financials 5.38%
5 Healthcare 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWBO
751
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
-25,000
Closed -$37K

Similar funds

Kovack Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Kovack Advisors held 787 positions worth $920M, up 4.7% from $879M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Kovack Advisors deployed $50.7M of net new capital in Q3 2021, opening 83 new positions and adding to 356 existing holdings. Its largest new stake was ProShares Short S&P500: 36,318 shares worth $2.21M.

By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, down from 48% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Idexx Laboratories, an estimated $1.51M trimmed.

  • Kovack Advisors's largest Q3 2021 buy was ProShares Short S&P500: 36,318 shares worth $2.21M.
  • Kovack Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $8.06M increase.
  • Kovack Advisors's biggest Q3 2021 reduction was Idexx Laboratories, cutting an estimated $1.51M.
  • Kovack Advisors fully exited abrdn Physical Precious Metals Basket Shares ETF in Q3 2021, selling an estimated $839K.
  • Kovack Advisors's ten largest holdings make up 21% of its $920M portfolio in Q3 2021.
  • Kovack Advisors opened 83 new positions and closed 80 in Q3 2021.
  • Kovack Advisors's portfolio value rose 4.7% quarter-over-quarter to $920M.

Based on Kovack Advisors's 13F filing for Q3 2021, filed 3 Nov 2021.